4//SEC Filing
Chawla Lakhmir S 4
Accession 0000920465-20-000139
CIK 0000920465other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 4:17 PM ET
Size
7.0 KB
Accession
0000920465-20-000139
Insider Transaction Report
Form 4
Chawla Lakhmir S
Chief Medical Officer
Transactions
- Award
Common Stock
2020-08-31$3.57/sh+550$1,964→ 13,161 total - Award
Employee Stock Option (Right to Buy)
2020-08-31+550→ 550 totalExercise: $4.20Exp: 2030-08-31→ Common Stock (550 underlying)
Footnotes (2)
- [F1]These shares were acquired on 08/31/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock options vest and become exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vest and become exercisable ratably on a monthly basis over the next three years.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001646626
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 4:17 PM ET
- Size
- 7.0 KB